The wisdom (or lack of) in prescribing opiates after tooth removal

A mother and a dentist team call for an end to routine opioid use for teens after wisdom tooth removal

The wisdom (or lack of) in prescribing opiates after tooth removalBy Amy Ma and Susan Sutherland Contributors We’re writing as a parent and a dentist to spread a message to parents and dental health-care providers across Canada: there are alternatives to prescribing opioids after wisdom teeth removal. Removing wisdom teeth is considered by many as a rite of passage for teenagers. It’s one of the…

Shoppers Drug Mart launches ecommerce platform for medical cannabis

Virtual team of professionals will provide counselling and support for patients

Shoppers Drug Mart launches ecommerce platform for medical cannabisCanadian pharmacy giant Shoppers Drug Mart has launched an online platform for the sale of medical cannabis. “As trusted medication experts, pharmacists have an important role to play in the safe and informed use of medical cannabis. Today's announcement is a leap forward for those looking for professional oversight and trusted support in this area,”…

Not all cannabis candies are created equal

Health Canada offers a framework for the sale of edible cannabis products before the October 2019 launch. Will we be ready?

Not all cannabis candies are created equalYou think October 2018 was complicated, wait until edible cannabis products are legalized by October 2019. It’s just a matter of time before the edible market represents the majority of the cannabis market in Canada. A study released last year suggested that 93 per cent of consumers supporting Ottawa’s legalization plans would try a cannabis-infused food…

Westleaf Cannabis closes on $20 million in financing

Company plans to open 20 to 30 retail stores under the banner Prairie Records over the next 12 to 24 months

Westleaf Cannabis closes on $20 million in financingCalgary-based Westleaf Cannabis has received strong validation of its innovative approach in the Canadian cannabis industry with the recent closing of $20 million in financing, including a $2.9-million strategic investment from Tilray Inc. Westleaf plans to open 20 to 30 retail stores over the next 12 to 24 months, subject to securing real estate, finalizing…

Canada’s free ride on U.S. drug development may end soon

A shift in U.S. drug pricing could cut pharmaceutical profits, meaning less money for research and development

Canada’s free ride on U.S. drug development may end soonBy Steven Globerman and Bacchus Barua The Fraser Institute In October, the administration of U.S. President Donald Trump outlined a plan that, if implemented, would substantially lower the amount the U.S. government will pay drug-makers for certain pharmaceuticals covered by its Medicare plan. Though limited in scope, Trump’s changes are a clear step toward controlling…

Cannabis consumption spending continues to rise in Canada

Canadians spent $5.9 billion on cannabis products in the third quarter, most of it purchased illegally, says StatsCan

Cannabis consumption spending continues to rise in CanadaCanadian household expenditure on cannabis (for medical and non-medical use) was up 1.1 per cent in the third quarter, following a 1.8 per cent increase in the second quarter, according to Statistics Canada. The federal agency reported on Wednesday that household expenditure on cannabis has increased for six consecutive quarters, averaging a growth rate of…

Dazed and confused: legalizing cannabis offers no payoff

Provinces and municipalities face a bevy of expenses and a web of regulations. And the tax benefits at all levels are questionable

Dazed and confused: legalizing cannabis offers no payoffYou might wonder how legislators could lose money by legalizing and taxing an addictive substance. Behold, Canadian officials have outdone themselves with the rollout of recreational cannabis. Provinces and municipalities, many already in financial dire straits, have revealed a bevy of legalization costs. Meanwhile, tax projections suggest relatively slim pickings, given the size of the…

Marijuana’s medical attributes vastly overstated

Pot’s benefits have been overstated by political advocates and scientists, whose bias may have tainted research results

Marijuana’s medical attributes vastly overstatedMarijuana users want society to believe the very thing they’ve told themselves for years – that the highs of marijuana far outweigh its lows when it comes to health and the effect on the masses. Informed minds that remain sober and less tainted by personal bias realize that’s probably not the case. Cannabis is demonstrably…

Too many bureaucratic hurdles for cannabis research

Why researchers are studying cannabis for promising anti-seizure medication

Too many bureaucratic hurdles for cannabis researchWe’ve lost many years of potentially important research on the use of cannabis as medicine because of polarized views of the ‘weed’ among researchers, policy-makers and the general public. On one side, there are those who see cannabis as a dangerous psychoactive drug that should be prohibited. On the other, there are those who view cannabis as…

Before implementing national pharmacare, look at what provinces already offer

Instead of using scarce health-care dollars broadly, we should identify and support those Canadians falling through the cracks

Before implementing national pharmacare, look at what provinces already offerModern medicines can improve health outcomes and quality of life for those stricken with illness. As a result, policy-makers and ordinary Canadians are understandably concerned about patient access, affordability and insurance coverage for prescrip­tion drugs. However, recent calls for a national pharmacare program would have many believe that Canadians without private drug insurance – about…